These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 12940072)
1. [Characterization of macrophage cell (THP-1) surface apoE and it's role in metabolism of cell lipids]. Liang P; Burgess JW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):337-40. PubMed ID: 12940072 [TBL] [Abstract][Full Text] [Related]
2. [Relationship between proteoglycans and apoE on the HepG2 cell surface]. Liang P; Burgess JW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):320-3. PubMed ID: 12940068 [TBL] [Abstract][Full Text] [Related]
3. ApoE of the HepG2 cell surface includes a major pool associated with chondroitin sulfate proteoglycans. Burgess JW; Liang P; Vaidyanath C; Marcel YL Biochemistry; 1999 Jan; 38(2):524-31. PubMed ID: 9888791 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II amplifies macrophage-driven atherosclerosis. Nobuhiko A; Suganuma E; Babaev VR; Fogo A; Swift LL; Linton MF; Fazio S; Ichikawa I; Kon V Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2143-8. PubMed ID: 15374850 [TBL] [Abstract][Full Text] [Related]
6. Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Rayner K; Chen YX; McNulty M; Simard T; Zhao X; Wells DJ; de Belleroche J; O'Brien ER Circ Res; 2008 Jul; 103(2):133-41. PubMed ID: 18566345 [TBL] [Abstract][Full Text] [Related]
7. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445 [TBL] [Abstract][Full Text] [Related]
8. High expression of apolipoprotein E impairs lipid storage and promotes cell proliferation in human adipocytes. Carmel JF; Tarnus E; Cohn JS; Bourdon E; Davignon J; Bernier L J Cell Biochem; 2009 Mar; 106(4):608-17. PubMed ID: 19130493 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels. Raffai RL; Loeb SM; Weisgraber KH Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220 [TBL] [Abstract][Full Text] [Related]
10. Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. Adachi H; Fujiwara Y; Kondo T; Nishikawa T; Ogawa R; Matsumura T; Ishii N; Nagai R; Miyata K; Tabata M; Motoshima H; Furukawa N; Tsuruzoe K; Kawashima J; Takeya M; Yamashita S; Koh GY; Nagy A; Suda T; Oike Y; Araki E Biochem Biophys Res Commun; 2009 Feb; 379(4):806-11. PubMed ID: 19094966 [TBL] [Abstract][Full Text] [Related]
11. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881 [TBL] [Abstract][Full Text] [Related]
12. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. Merched AJ; Chan L Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565 [TBL] [Abstract][Full Text] [Related]
13. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation. Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191 [TBL] [Abstract][Full Text] [Related]
14. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083 [TBL] [Abstract][Full Text] [Related]
15. Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro. Schapira K; Burkly LC; Zheng TS; Wu P; Groeneweg M; Rousch M; Kockx MM; Daemen MJ; Heeneman S Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2021-7. PubMed ID: 19762780 [TBL] [Abstract][Full Text] [Related]
16. Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages. Persson J; Nilsson J; Lindholm MW Lipids Health Dis; 2006 Jun; 5():17. PubMed ID: 16800873 [TBL] [Abstract][Full Text] [Related]
17. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis. Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631 [TBL] [Abstract][Full Text] [Related]
18. A novel efflux-recapture process underlies the mechanism of high-density lipoprotein cholesteryl ester-selective uptake mediated by the low-density lipoprotein receptor-related protein. Vassiliou G; McPherson R Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1669-75. PubMed ID: 15178567 [TBL] [Abstract][Full Text] [Related]
19. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147 [TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]